Ieq Capital, LLC Gilead Sciences, Inc. Transaction History

Ieq Capital, LLC

$10.1 Billion
Q4 2024

A detailed history of Ieq Capital, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ieq Capital, LLC holds 66,660 shares of GILD stock, worth $7.06 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

66,660

Previous 82,251 18.96%

Holding current value

$7.06 Million

Previous $6.89 Million 10.69%

% of portfolio

0.06%

Previous 0.09%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	SELL	$83.95 - $97.9 $1.31 Million - $1.53 Million	-15,591 Reduced 18.96%	66,660 $6.16 Million
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $868,067 - $1.09 Million	13,036 Added 18.83%	82,251 $6.89 Million
Q2 2024 Aug 12, 2024	BUY	$63.15 - $72.88 $154,906 - $178,774	2,453 Added 3.67%	69,215 $4.75 Million
Q1 2024 May 08, 2024	SELL	$71.58 - $87.29 $154,111 - $187,935	-2,153 Reduced 3.12%	66,762 $4.89 Million
Q4 2023 Feb 07, 2024	BUY	$73.27 - $83.09 $602,279 - $682,999	8,220 Added 13.54%	68,915 $5.58 Million
Q3 2023 Nov 03, 2023	BUY	$73.94 - $80.67 $68,986 - $75,265	933 Added 1.56%	60,695 $4.55 Million
Q2 2023 Aug 07, 2023	BUY	$76.01 - $86.7 $135,905 - $155,019	1,788 Added 3.08%	59,762 $4.61 Million
Q1 2023 May 01, 2023	SELL	$77.31 - $88.08 $299,576 - $341,310	-3,875 Reduced 6.27%	57,974 $4.81 Million
Q4 2022 Feb 03, 2023	BUY	$62.32 - $89.47 $308,733 - $443,234	4,954 Added 8.71%	61,849 $5.31 Million
Q3 2022 Nov 03, 2022	BUY	$59.54 - $68.01 $661,965 - $756,135	11,118 Added 24.29%	56,895 $3.51 Million
Q2 2022 Jul 27, 2022	SELL	$57.72 - $65.01 $111,630 - $125,729	-1,934 Reduced 4.05%	45,777 $2.83 Million
Q1 2022 Apr 26, 2022	SELL	$57.92 - $72.58 $557,711 - $698,872	-9,629 Reduced 16.79%	47,711 $2.84 Million
Q4 2021 Jan 31, 2022	BUY	$64.88 - $73.64 $97,255 - $110,386	1,499 Added 2.68%	57,340 $4.16 Million
Q3 2021 Nov 09, 2021	BUY	$67.69 - $73.03 $1.02 Million - $1.1 Million	15,108 Added 37.09%	55,841 $3.9 Million
Q2 2021 Jul 29, 2021	BUY	$63.47 - $69.35 $1.12 Million - $1.23 Million	17,718 Added 76.98%	40,733 $2.81 Million
Q1 2021 May 04, 2021	BUY	$60.0 - $68.46 $341,580 - $389,742	5,693 Added 32.87%	23,015 $1.49 Million
Q4 2020 Feb 03, 2021	SELL	$56.65 - $64.55 $259,910 - $296,155	-4,588 Reduced 20.94%	17,322 $1.01 Million
Q3 2020 Nov 03, 2020	BUY	$62.1 - $78.08 $304,600 - $382,982	4,905 Added 28.84%	21,910 $1.38 Million
Q2 2020 Jul 31, 2020	BUY	$72.34 - $84.0 $215,934 - $250,740	2,985 Added 21.29%	17,005 $1.31 Million
Q1 2020 May 07, 2020	BUY	$62.63 - $80.22 $339,642 - $435,033	5,423 Added 63.08%	14,020 $1.05 Million
Q4 2019 Feb 11, 2020	SELL	$61.62 - $67.78 $103,583 - $113,938	-1,681 Reduced 16.36%	8,597 $558,000
Q4 2019 Feb 04, 2020	BUY	$61.62 - $67.78 $633,330 - $696,642	10,278 New	10,278 $359,000

Others Institutions Holding GILD

# of Institutions

2,030

Shares Held

1.01B

Call Options Held

10M

Put Options Held

8.9M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $133B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.

Account